Publications by authors named "C Eyermann"

Claim this Profile
S
Small molecule inhibitors of mannan-binding lectin-associated serine Proteases-2 and-3.
Mina C Nakhla, Janelle Comita, Adam B Shapiro, Samir H Moussa, April Chen, Charles J Eyermann

Eur J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors.
Gyles E Cozier, Lauren B Coulson, Charles J Eyermann, Gregory S Basarab, Sylva L Schwager

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the F-radiolabel.
Sulan Xu, Chun-Han Huang, Christopher Eyermann, Georgios V Georgakis, Nashaat Turkman

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
ΔNp63 Regulates Homeostasis, Stemness, and Suppression of Inflammation in the Adult Epidermis.
Christopher E Eyermann, Xi Chen, Ozge S Somuncu, Jinyu Li, Alexander N Joukov

J Invest Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Melissa L Boby, Daren Fearon, Matteo Ferla, Mihajlo Filep, Lizbé Koekemoer, Charles J Eyermann

Science· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis